Impressive they’ve managed to get the raising away at this...

Impressive they’ve managed to get the raising away at this price. Factoring for the options as well it’s prob equiv to about a 10.5c raising - still excellent.

I find it a bit disingenuous that they must surely have had material and quantifiable information available about the hm3 results well before this suspension but have elected to only release qualitative descriptions.
I also suspect that despite the hyperbole the results may not be as exciting overall as expected (even if there’s a few nice headline grabs in there).

If so why raise before the release of amazing results that would only push the price higher and allow them to raise even more. I’d also question, given they surely must have some material and quantifiable info about these results how well they’ve been able to manage disclosure during the CR process.